Coronavirus (COVID-19)
Learn more
A MULTICENTER, RANDOMZIED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, ACTIVE CONTROLLED 8-WEEK STUDY TO EVALUATE THE EFFECT OF SACUBITRIL/VALSARTAN VERSUS VALSARTAN ALONE ON CHANGES IN NT-proBNP.
Dr. Jaiswal and the Heart Failure Team will participate in this study investigating certain blood tests that may help identify patients that are at increased risk of death or re-hospitalized again after discharge. This blood test will reflect elevated pressures or stress on the heart to help identify patients at higher risk.
ELIGIBILITY CRITERIA
Please contact Khadija El Aoudi at 860-972-3167 or by email at Khadija.elaoudi@hhchealth.org for more information
Backus Hospital
Charlotte Hungerford Hospital
Hartford Hospital
The Hospital of Central Connecticut
MidState Medical Center
St. Vincent’s Medical Center
Windham Hospital
View all Medical Group Locations
Get the latest healthcare news directly in your inbox.
To receive our health news text alerts / text StartHere to 85209